Skip to: Content
Skip to: Site Navigation
Skip to: Search

THURSDAY, NOVEMBER 26, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: restructuring

restructuring stories: 24 news summaries

21 - 24 of 24 Stories | << Prev 1 2

Yahoo to Reorganize in
Wake of Microsoft Bid

Company execs quit amid changes

(Newser) - Regrouping in the aftermath of Microsoft’s takeover bid, Yahoo plans to consolidate its myriad branches, the Wall Street Journal reports. President Susan Decker aims to centralize the mail, search, and home-page teams to help boost earnings and justify its rejection of Microsoft’s $47.5 billion offer; some executives... More »

MORE ABOUT:
Yahoo Susan Decker Flickr restructuring quitting

IAC, Liberty Make Peace Over Spin-Offs

Media bosses Malone and Diller finally
bury the hatchet

(Newser) - The months-long feud between media barons John Malone and Barry Diller over IAC spin-offs has ended amicably, the Wall Street Journal reports. Malone's Liberty Media, the majority shareholder in IAC, will drop its opposition to Diller's plans to divide IAC/Interactive Corp into five separate entities. Liberty will have the right... More »

Profits Slide
as Dell
Streamlines

6.5% drop on consumer slump, 'slow as molasses' turnaround

(Newser) - Dell posted a 6.5% decline in profits for its fiscal fourth quarter yesterday, citing slowed consumer spending and the cost of restructuring, which included slashing thousands of jobs, the Wall Street Journal reports. The Dell results are likely to cause concern about other tech stocks—especially those that rely... More »

MORE ABOUT:
Dell Michael Dell restructuring tech stocks tech sector job cuts computer quarterly results

Biotech Giant Slashes Jobs

World biggest biotech cuts 2,600 jobs in $2B restructuring

(Newser) - Biotech giant Amgen is slashing spending by $1.9 billion by cutting up to 14 percent of its workforce— 2,600 jobs—and closing some production facilities. The restructuring was triggered by plummeting sales of the company's anemia drug Aranesp. The shake up demonstrates that biotech operations are not immune... More »

MORE ABOUT:
biotechnology Amgen Aranesp Genentech restructuring Cera Roche Holding Kevin Sharer

21 - 24 of 24 Stories | << Prev 1 2